Oppenheimer & CO Inc Immunocore Holdings PLC Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$60.14 - $75.36 $310,202 - $388,706
-5,158 Reduced 26.82%
14,072 $914,000
Q4 2023

Feb 13, 2024
BUY
$42.85 - $69.5 $824,005 - $1.34 Million
19,230 New
19,230 $1.31 Million
Q2 2023

Aug 02, 2023
BUY
$48.54 - $61.64 $168,725 - $214,260
3,476 New
3,476 $208,000
Q4 2022

Feb 07, 2023
BUY
$45.51 - $65.08 $290,581 - $415,535
6,385 New
6,385 $364,000

Others Institutions Holding IMCR

# of Institutions
140
Shares Held
40.8M
Call Options Held
197K
Put Options Held
451K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email